SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $145,000 | -48.6% | 121,809 | +223.3% | 0.00% | – |
| Q1 2021 | $282,000 | -88.9% | 37,680 | -83.9% | 0.00% | -100.0% |
| Q4 2020 | $2,536,000 | +50.1% | 233,687 | +22.2% | 0.00% | 0.0% |
| Q3 2020 | $1,690,000 | -31.8% | 191,177 | -17.7% | 0.00% | -33.3% |
| Q2 2020 | $2,477,000 | +392.4% | 232,429 | +174.0% | 0.00% | +200.0% |
| Q1 2020 | $503,000 | -50.5% | 84,818 | -42.3% | 0.00% | 0.0% |
| Q4 2019 | $1,017,000 | +34.3% | 147,077 | +101.6% | 0.00% | 0.0% |
| Q3 2019 | $757,000 | -13.3% | 72,938 | -22.7% | 0.00% | 0.0% |
| Q2 2019 | $873,000 | -15.2% | 94,326 | -16.3% | 0.00% | 0.0% |
| Q1 2019 | $1,030,000 | +107.7% | 112,690 | +26.8% | 0.00% | 0.0% |
| Q4 2018 | $496,000 | +303.3% | 88,882 | +763.7% | 0.00% | – |
| Q3 2018 | $123,000 | – | 10,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |